In continuation to its letter No. JPL/CS/1673/2020 dated 31st December, 2020, Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Jenburkt Pharmaceuticals has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 05th February, 2021, at the Registered Office of the Company, to consider and approve, the un-audited financial results for the quarter and nine months ended on 31st December, 2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: